Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2023 Jul 26;10:1256685. doi: 10.3389/fmed.2023.1256685

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report

Ningning Yan 1,†, Ziheng Zhang 1,†, Sanxing Guo 1, Shujing Shen 2,*, Xingya Li 1,*
PMCID: PMC10411721  PMID: 37564044

In the published article, the author names were incorrectly written as “Ning Yan, Zi Zhang, San Guo, Shu Shen, Xing Li”. The correct spellings are “Ningning Yan, Ziheng Zhang, Sanxing Guo, Shujing Shen, Xingya Li”.

In the published article, there was a mistake in the Author contributions. The correct Author contributions appears below.

Author contributions

NNY, ZHZ, SJS, and XYL wrote the manuscript. NNY, ZHZ, and SXG prepared Figures and Tables. All authors have reviewed the manuscript and gave their consent to publication. All authors contributed to the article and approved the submitted version.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES